Studies have confirmed that high NSUN2 expression is a poor prognostic factor in GC and HNSC [14, 43], which highlights that NSUN2 serves as a poor prognostic factor and can be used as a pan-cancer biomarker. This evidence concerns the gene NSUN2 and gastric cancer.